Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing Phase 3 AR-301 Clinical Trial in Ventilator Associated Pneumonia

      Clinical Trials
      Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced the enrollment...

      Quotient Limited Announces CE Mark for its SARS-CoV-2 Antibody Microarray

      FDA Approvals
      Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, announced that it has completed the process for declaring conformity to the essential requirements...

      GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 Vaccine Development

      Drug Development
      GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced that Beijing- and Philadelphia-based Sino Biological, Inc....

      Trio pharmaceuticals and ajinomoto bio pharma services enter into a development collaboration for a novel antibody therapeutic

      Drug Development
      Trio Pharmaceuticals, Inc., a cancer therapeutics company developing novel dual action antibody drugs, and Ajinomoto Bio-Pharma Services, have entered a development collaboration to evaluate...

      Gilead’s drug remdesivir gets US FDA’s emergency use authorisation for COVID-19

      FDA Approvals
      Gilead was granted EUA by U.S. FDA for the investigational antiviral remdesivir to treat COVID-19. The EUA will facilitate broader use of remdesivir to...

      Fujifilm Diosynth Biotechnologies Teams with COVID-19 Therapeutics Accelerator

      Drug Development
      FUJIFILM Diosynth Biotechnologies, a world leading biologics-Contract Development and Manufacturing Organization (CDMO), today announced that it will reserve manufacturing capacity for a future COVID-19...

      FDA Grants Hardy Diagnostics Emergency Use Authorization (EUA) for a Rapid Antibody Test Kit for COVID-19

      FDA Approvals
      Hardy Diagnostics, a medical device manufacturer based in Santa Maria, California, announced FDA EUA approval on April 24th for a new in vitro diagnostic...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector .....Read More

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.